DJIA 16,472.37 200.36 1.23%
NASDAQ 4,707.78 80.69 1.74%
S&P 500 1,951.36 27.54 1.43%
market minute promo

Gilead Sciences (NASDAQ: GILD)

98.28 0.01 (0.01%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GILD $98.28 0.01%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $95.54
Previous Close $98.27
Daily Range $94.37 - $98.31
52-Week Range $85.95 - $123.37
Market Cap $144.2B
P/E Ratio 10.33
Dividend (Yield) $1.72 (1.8%)
Ex-Dividend Date
Dividend Pay Date
Volume 19,106,442
Average Daily Volume 13,246,451
Current FY EPS $11.99




Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website:

News & Commentary

5 Stocks We Bought Recently

Here are our contributors' latest investments and why they bought them.

7 Quality U.S. Stocks That Can Be Purchased At A Discount Right Now

Gilead Will Rebound In The Fourth Quarter

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

Morning Market Losers

Benzinga's Top Downgrades

Analysts' Actions -- Google, Gilead, AIG and More

Revisiting NASH: Therapeutic Targets And The Competitive Landscape

Is Gilead Sciences Worth $98?

Stock Market News for October 01, 2015

See More GILD News...

GILD's Top Competitors

GILD $98.28 (0.01%)
Current stock: GILD
AMGN $142.47 (1.60%)
Current stock: AMGN
CELG $116.39 (3.13%)
Current stock: CELG
$0.00 (0.00%)
Current stock: